Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1998 2
1999 1
2000 4
2001 8
2002 23
2003 14
2004 9
2005 13
2006 11
2007 13
2008 9
2009 5
2010 5
2011 6
2012 5
2013 2
2014 3
2015 1
2016 2
2017 2
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 12566359

131 results

Results by year

Filters applied: . Clear all
Page 1
Paclitaxel coating reduces in-stent intimal hyperplasia in human coronary arteries: a serial volumetric intravascular ultrasound analysis from the Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT).
Hong MK, Mintz GS, Lee CW, Song JM, Han KH, Kang DH, Song JK, Kim JJ, Weissman NJ, Fearnot NE, Park SW, Park SJ; ASian Paclitaxel-Eluting Stent Clinical Trial. Hong MK, et al. Circulation. 2003 Feb 4;107(4):517-20. doi: 10.1161/01.cir.0000054163.42072.d4. Circulation. 2003. PMID: 12566359 Clinical Trial.
Impact of preinterventional arterial remodeling on neointimal hyperplasia after implantation of (non-polymer-encapsulated) paclitaxel-coated stents: a serial volumetric intravascular ultrasound analysis from the ASian Paclitaxel-Eluting Stent Clinical Trial (ASPECT).
Mintz GS, Tinana A, Hong MK, Lee CW, Kim JJ, Fearnot NE, Park SW, Park SJ, Weissman NJ. Mintz GS, et al. Circulation. 2003 Sep 16;108(11):1295-8. doi: 10.1161/01.CIR.0000091254.73351.D6. Epub 2003 Sep 2. Circulation. 2003. PMID: 12952833 Clinical Trial.
Two-year follow-up of the quantitative angiographic and volumetric intravascular ultrasound analysis after nonpolymeric paclitaxel-eluting stent implantation: late "catch-up" phenomenon from ASPECT Study.
Park DW, Hong MK, Mintz GS, Lee CW, Song JM, Han KH, Kang DH, Cheong SS, Song JK, Kim JJ, Weissman NJ, Park SW, Park SJ. Park DW, et al. J Am Coll Cardiol. 2006 Dec 19;48(12):2432-9. doi: 10.1016/j.jacc.2006.08.033. Epub 2006 Nov 28. J Am Coll Cardiol. 2006. PMID: 17174179 Free article. Clinical Trial.
Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease.
Waseda K, Miyazawa A, Ako J, Hasegawa T, Tsujino I, Sakurai R, Yock PG, Honda Y, Kandzari DE, Leon MB, Fitzgerald PJ; ENDEAVOR IV Trial Investigators. Waseda K, et al. JACC Cardiovasc Interv. 2009 Aug;2(8):779-84. doi: 10.1016/j.jcin.2009.05.015. JACC Cardiovasc Interv. 2009. PMID: 19695548 Free article. Clinical Trial.
A paclitaxel-eluting stent for the prevention of coronary restenosis.
Park SJ, Shim WH, Ho DS, Raizner AE, Park SW, Hong MK, Lee CW, Choi D, Jang Y, Lam R, Weissman NJ, Mintz GS. Park SJ, et al. N Engl J Med. 2003 Apr 17;348(16):1537-45. doi: 10.1056/NEJMoa021007. N Engl J Med. 2003. PMID: 12700373 Free article. Clinical Trial.
Vascular response to sirolimus-eluting stents delivered with a nonaggressive implantation technique: comparison of intravascular ultrasound results from the multicenter, randomized E-SIRIUS, and SIRIUS trials.
Hoffmann R, Guagliumi G, Musumeci G, Reimers B, Petronio AS, Disco C, Amoroso G, Moses JW, Fitzgerald PJ, Schofer J, Leon MB, Breithardt G. Hoffmann R, et al. Catheter Cardiovasc Interv. 2005 Dec;66(4):499-506. doi: 10.1002/ccd.20542. Catheter Cardiovasc Interv. 2005. PMID: 16273564 Clinical Trial.
Comparison of quantitative angiographic parameters with the magnitude of neointimal hyperplasia measured by volumetric intravascular ultrasound in patients treated with bare metal and nonpolymeric paclitaxel-coated stents.
Mintz GS, Hong MK, Raizner AE, Lee CW, Kim JJ, Escolar E, Fearnot NE, Park SW, Park SJ, Weissman NJ. Mintz GS, et al. Am J Cardiol. 2005 Jan 1;95(1):105-7. doi: 10.1016/j.amjcard.2004.08.071. Am J Cardiol. 2005. PMID: 15619403 Clinical Trial.
Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up.
Degertekin M, Serruys PW, Foley DP, Tanabe K, Regar E, Vos J, Smits PC, van der Giessen WJ, van den Brand M, de Feyter P, Popma JJ. Degertekin M, et al. Circulation. 2002 Sep 24;106(13):1610-3. doi: 10.1161/01.cir.0000034447.02535.d5. Circulation. 2002. PMID: 12270850 Clinical Trial.
131 results